Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Circulation
    January 2026
  1. PAUWELS R, Dausin C, Ruiz-Carmona S, De Bosscher R, et al
    Wearable-Derived Training Load and Coronary Atherosclerosis in Middle-Aged and Older Athletes and Physically Active Controls: A New Perspective From the Master@Heart Study.
    Circulation. 2026 Jan 29. doi: 10.1161/CIRCULATIONAHA.125.077117.
    >> Share

  2. CHANG Q, Li C, Xu Z
    An Atypical Presentation of an Occlusion Myocardial Infarction Requiring Urgent Revascularization.
    Circulation. 2026;153:282-284.
    >> Share

  3. ARMSTRONG A, Pugh D, Basu N, Dhaun N, et al
    Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.
    Circulation. 2026;153:266-281.
    >> Share

  4. CHO Y, Kang D, Lim H, Lee H, et al
    Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study.
    Circulation. 2026 Jan 23. doi: 10.1161/CIRCULATIONAHA.125.078919.
    >> Share

  5. HE J, Zhu Y
    Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
    Circulation. 2026;153:185-188.
    >> Share

  6. PYRPYRIS N, Dimitriadis K, Tsioufis K
    Letter by Pyrpyris et al Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e14-e15.
    >> Share

  7. MAENG M, Thrane PG, Erlinge D, Maehara A, et al
    Response by Maeng et al to Letters Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e17-e18.
    >> Share

  8. SUN P
    Letter by Sun Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e16.
    >> Share

  9. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
    Correction to: Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
    Circulation. 2026;153:e19.
    >> Share

  10. MUNZEL T, Luscher T, Kramer CM, Churchwell K, et al
    Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federat
    Circulation. 2026 Jan 20. doi: 10.1161/CIRCULATIONAHA.125.079034.
    >> Share

  11. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
    Correction to: Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
    Circulation. 2026;153:e11.
    >> Share

  12. SITTICHOKKANANON A, Garfield V, Chiesa ST
    Response by Sittichokkananon et al to Letter Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
    Circulation. 2026;153:e6-e7.
    >> Share

  13. YANG S, Lu Y
    Letter by Yang and Lu Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
    Circulation. 2026;153:e4-e5.
    >> Share

  14. ZHAO YT
    Letter by Zhao Regarding Article, "Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial".
    Circulation. 2026;153:e8-e9.
    >> Share

  15. FEARON WF, Terada K, Takahashi K, Skoda A, et al
    Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial.
    Circulation. 2026;153:7-17.
    >> Share

  16. LEONARDI S, Landi A, Zito A, Branca M, et al
    Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome.
    Circulation. 2026 Jan 6. doi: 10.1161/CIRCULATIONAHA.125.077174.
    >> Share

    December 2025
  17. GUNAWARDENE MA, Schmidt B, Peichl P, Nair D, et al
    Life-Threatening Delayed Myocardial Ischemia and Malignant Arrhythmias Occurring After Pulsed Field Ablation of Atrial Fibrillation.
    Circulation. 2025 Dec 25. doi: 10.1161/CIRCULATIONAHA.125.077983.
    >> Share

  18. HENRIKSEN PA
    Challenges of Clinical Trials in Cardio-Oncology: Navigating Surrogate Outcomes and Identifying Patients at Risk of Late Cardiovascular Complications.
    Circulation. 2025;152:1756-1758.
    >> Share

  19. TRAN AH, Zaidi AH, Bolger AF, Del Brutto OH, et al
    Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Dec 16. doi: 10.1161/CIR.0000000000001390.
    >> Share

  20. XU L, Hrybouski S, Liao TE, Dong JN, et al
    Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.
    Circulation. 2025;152:1608-1620.
    >> Share

  21. SHARIF A
    Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk-Reducing Intervention in Kidney Failure.
    Circulation. 2025;152:1591-1593.
    >> Share

  22. TOMCZYK M, Kraszewska I, Li G, Hayes MJ, et al
    Chordin-Like 1 mRNA Therapy for Acute Myocardial Infarction.
    Circulation. 2025;152:1586-1589.
    >> Share

  23. RAJKUMAR CA, Foley MJ, Ahmed-Jushuf F, Chotai S, et al
    The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
    Circulation. 2025;152:1541-1551.
    >> Share

  24. FETTERMAN JL, Chinnery PF, McClellan R, Wallace DC, et al
    Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Dec 2. doi: 10.1161/CIR.0000000000001393.
    >> Share

  25. TSIMIKAS S, Szarek M, Cobbaert CM, Romijn F, et al
    Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes after Acute Coronary Syndrome.
    Circulation. 2025 Dec 1. doi: 10.1161/CIRCULATIONAHA.125.073855.
    >> Share

    November 2025
  26. CHEN Y
    Letter by Chen Regarding Article, "Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality".
    Circulation. 2025;152:e407.
    >> Share

  27. TULETA I, Venugopal H, O'Leary K, Zheng D, et al
    Fibroblast-Specific Loss of TGF-beta Signaling Mediates Lipomatous Metaplasia in the Infarcted Heart.
    Circulation. 2025;152:1423-1435.
    >> Share

  28. DAMLUJI AA, Nanna MG, Mason P, Lowenstern A, et al
    Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Nov 18. doi: 10.1161/CIR.0000000000001387.
    >> Share

  29. LANDSTROM AP, Ferguson JF, James CA, Key KV, et al
    Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association.
    Circulation. 2025 Nov 13. doi: 10.1161/CIR.0000000000001385.
    >> Share

  30. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;152:e402.
    >> Share

  31. OHAYON-STECKEL L, Zhang X, Haque S, Uddin MA, et al
    miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.124.073527.
    >> Share

  32. DUDUM R, Jain SS, Mastrodicasa D, Furst A, et al
    Effects of Real-Time Notification of AI-Detected Incidental Coronary Artery Calcium on Statin Prescription: the NOTIFY-PICTURE Trial.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.078155.
    >> Share

  33. JOHANSEN ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sanchez C, et al
    High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.077801.
    >> Share

  34. SLIPCZUK L, Blankstein R, Bucciarelli-Ducci C, Braun LT, et al
    State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Nov 10. doi: 10.1161/CIR.0000000000001394.
    >> Share

  35. LEMESLE G, Didier R, Diallo A, Dromas H, et al
    Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-term Anticoagulation: a Meta-analysis of Randomized Clinical Trials.
    Circulation. 2025 Nov 8. doi: 10.1161/CIRCULATIONAHA.125.077141.
    >> Share

  36. RAPOSEIRAS ROUBIN S, Abu Assi E, Jimenez Mendez C, Minguez de la Guia E, et al
    Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial.
    Circulation. 2025 Nov 7. doi: 10.1161/CIRCULATIONAHA.125.075388.
    >> Share

  37. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
    Correction to: Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
    Circulation. 2025;152:e371.
    >> Share

    October 2025
  38. RUEL M
    Introduction to the 2025 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2025;152:1187.
    >> Share

  39. DONOGHUE AJ, Auerbach M, Banerjee A, Blewer AL, et al
    Part 12: Resuscitation Education Science: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  40. HIRSCH KG, Amorim E, Coppler PJ, Drennan IR, et al
    Part 11: Post-Cardiac Arrest Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  41. DEL RIOS M, Bartos JA, Panchal AR, Atkins DL, et al
    Part 1: Executive Summary: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  42. PANCHAL AR, Bartos JA, Wyckoff MH, Drennan IR, et al
    Part 2: Evidence Evaluation and Guidelines Development: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  43. JOYNER BL JR, Dewan M, Bavare A, de Caen A, et al
    Part 6: Pediatric Basic Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  44. ELMER J, Atkins DL, Daya MR, Del Rios M, et al
    Part 3: Ethics: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  45. CAO D, Arens AM, Chow SL, Easter SR, et al
    Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  46. KLEINMAN ME, Buick JE, Huber N, Idris AH, et al
    Part 7: Adult Basic Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  47. LEE HC, Strand ML, Finan E, Illuzzi J, et al
    Part 5: Neonatal Resuscitation: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  48. DEZFULIAN C, Cabanas JG, Buckley JR, Cash RE, et al
    Part 4: Systems of Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  49. LASA JJ, Dhillon GS, Duff JP, Hayes J, et al
    Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  50. WIGGINTON JG, Agarwal S, Bartos JA, Coute RA, et al
    Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    >> Share

  51. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Andersen JT, et al
    Response by Windfeld-Mathiasen et al to Letter Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
    Circulation. 2025;152:e296-e297.
    >> Share

  52. KING SJ, Furst A, Fan J, Chen TP, et al
    Comparison of the Pooled Cohort and the PREVENT Cardiovascular Disease Risk Equations in the Veterans Health Administration.
    Circulation. 2025;152:1183-1185.
    >> Share

  53. KORNELIUS E
    Letter by Kornelius Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
    Circulation. 2025;152:e295.
    >> Share

  54. KOLE A, Joshi PH
    Clear as Mud: Determining the Stage of Prevention in Cardiovascular Disease.
    Circulation. 2025;152:1123-1125.
    >> Share

  55. REGAN JA, Laitner MH, Dzau VJ
    A Crossroads in Cardiovascular Medicine: Progress and Barriers to Impact.
    Circulation. 2025;152:1166-1173.
    >> Share

  56. CHEN X, Yu X, Zhong S, Sha P, et al
    ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury.
    Circulation. 2025 Oct 20. doi: 10.1161/CIRCULATIONAHA.125.075220.
    >> Share

  57. FORAKER R, Sperling L, Bratzke L, Budoff M, et al
    Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Oct 16. doi: 10.1161/CIR.0000000000001382.
    >> Share

  58. KHAN SS, Fisher SA
    Bending the Curve in Maternal Mortality: Pregnancy as a Moment for Cardiovascular Disease Prevention.
    Circulation. 2025;152:1056-1059.
    >> Share

  59. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
    Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
    Circulation. 2025;152:1044-1055.
    >> Share

  60. OREN O, Libby P
    Incorporating Management of Clonal Hematopoiesis of Indeterminate Potential Into Cardiovascular Practice.
    Circulation. 2025;152:975-977.
    >> Share

    September 2025
  61. VONGPATANASIN W, Abraham J, Giacona JM
    Subclinical Primary Aldosteronism: A Potential New Target in Cardiovascular Prevention?
    Circulation. 2025;152:924-926.
    >> Share

  62. SECHI LA, Bulfone L, Catena C
    Letter by Sechi et al Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
    Circulation. 2025;152:e265-e266.
    >> Share

  63. BHATIA HS, Tsimikas S
    Response by Bhatia and Tsimikas to Letter Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
    Circulation. 2025;152:e267-e268.
    >> Share

  64. PETEK BJ, Churchill TW, Moulson N, Baggish AL, et al
    Sudden Cardiac Arrest and Death Secondary to Congenital Coronary Artery Abnormalities in Young Competitive Athletes.
    Circulation. 2025;152:971-973.
    >> Share

  65. GENTILE F, Carapellucci E, Uggenti V, Lorenzoni V, et al
    Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults.
    Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074198.
    >> Share

  66. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
    Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults.
    Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074433.
    >> Share

  67. GAN J, Zhao R, Zheng D, Peng Y, et al
    PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux.
    Circulation. 2025 Sep 24. doi: 10.1161/CIRCULATIONAHA.124.072312.
    >> Share

  68. FENG S, Wang Z, Sun R
    Letter by Feng et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
    Circulation. 2025;152:e239-e240.
    >> Share

  69. ZHONG Y, Lai R, Deng X
    Letter by Zhong et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
    Circulation. 2025;152:e241-e242.
    >> Share

  70. JI Y, Chen LY, Zhang MJ
    Response by Ji et al to Letters Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
    Circulation. 2025;152:e243-e244.
    >> Share

  71. LEVINE GN, Carney RM, Cohen BE, Dunn SL, et al
    Post-Myocardial Infarction Psychological Distress: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Sep 22. doi: 10.1161/CIR.0000000000001381.
    >> Share

  72. COUTINHO T
    The Geometry of Aging: New Angles on Cardiovascular Risk.
    Circulation. 2025;152:762-764.
    >> Share

  73. HUDED CP, Spertus JA, Jones PG, O'Brien SM, et al
    Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.
    Circulation. 2025 Sep 5. doi: 10.1161/CIRCULATIONAHA.125.073591.
    >> Share

  74. SHI F, Zheng B, Liu Y
    Letter by Shi et al Regarding Article "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e71-e72.
    >> Share

  75. NAMBI V, de Lemos JA, Ballantyne CM
    A Proposal to Elevate the Status of Troponin and B-Type Natriuretic Peptides as Atherosclerotic Cardiovascular Disease Risk Enhancers.
    Circulation. 2025;152:567-569.
    >> Share

  76. KUEHN BM
    Microplastics Exposure Linked to Cardiovascular Disease Risk, Chronic Health Conditions.
    Circulation. 2025;152:630-631.
    >> Share

  77. SILBERNAGEL G, Wen Y, Konrad RJ
    Response by Silbernagel et al to Letters Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e73-e74.
    >> Share

  78. HUANG J
    Letter by Huang Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e69-e70.
    >> Share

  79. CROON PM, Dhingra LS, Biswas D, Oikonomou EK, et al
    Phenotypic Selectivity of Artificial Intelligence-enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction.
    Circulation. 2025 Sep 1. doi: 10.1161/CIRCULATIONAHA.125.076279.
    >> Share

    August 2025
  80. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Aug 28. doi: 10.1161/CIR.0000000000001355.
    >> Share

  81. CHEN BY, Zhu H, Li YL, Zhang J, et al
    Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells.
    Circulation. 2025 Aug 27. doi: 10.1161/CIRCULATIONAHA.125.074837.
    >> Share

  82. WU J, Zheng Y
    Letter by Wu and Zheng Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
    Circulation. 2025;152:e67.
    >> Share

  83. HO FK, Sattar N, Welsh P
    Response by Ho et al to Letter Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
    Circulation. 2025;152:e68.
    >> Share

  84. QIN D, Modanwal R, Ghazi M, Corbalan JJ, et al
    Reformulation of the Necroptosis Pathway in Reperfused Myocardial Infarction.
    Circulation. 2025;152:486-488.
    >> Share

  85. BERRY C, Carberry J, Dharmakumar R
    Intramyocardial Hemorrhage After Myocardial Infarction: A Prognostic Outcome for Clinical Practice and Trials.
    Circulation. 2025;152:349-351.
    >> Share

  86. VIDOT DC
    Up in Smoke: No Association Between Cannabis Smoking and Cardiovascular Events Among Older Military Veterans With Coronary Artery Disease.
    Circulation. 2025;152:366-368.
    >> Share

  87. LAWN RB, Murchland AR, Thurston RC, Marquez C, et al
    Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II.
    Circulation. 2025 Aug 11:10.1161/CIRCULATIONAHA.124.073592.
    >> Share

  88. STEPANIAN A, Travers RJ, Tesfu A, Wolter NL, et al
    Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.
    Circulation. 2025 Aug 5. doi: 10.1161/CIRCULATIONAHA.125.073610.
    >> Share

  89. BECKMAN JA, Drooz AT, Farber A, Hamdan A, et al
    The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia.
    Circulation. 2025;152:346-348.
    >> Share

  90. TABAK RG, Kandula NR, Angell SY, Brewer LC, et al
    Implementation of Evidence-Based Behavioral Interventions for Cardiovascular Disease Prevention in Community Settings: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Aug 4. doi: 10.1161/CIR.0000000000001349.
    >> Share

    July 2025
  91. WERESKI R, Morrow DA, Mills NL
    Unstable Angina Refined.
    Circulation. 2025;152:213-216.
    >> Share

  92. WANG Q, Ismahil MA, Zhu Y, Rokosh G, et al
    CD206(+)IL-4Ralpha(+) Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
    Circulation. 2025;152:257-273.
    >> Share

  93. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
    Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
    Circulation. 2025 Jul 25. doi: 10.1161/CIRCULATIONAHA.125.073937.
    >> Share

  94. KEYHANI S, Cohen BE, Vali M, Hoggatt KJ, et al
    Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease.
    Circulation. 2025 Jul 21. doi: 10.1161/CIRCULATIONAHA.124.073193.
    >> Share

  95. CARBONNEAU M, Li Y, Qu Y, Zheng Y, et al
    DNA Methylation Signatures of Cardiovascular Health Provide Insights Into Diseases.
    Circulation. 2025 Jul 14:10.1161/CIRCULATIONAHA.124.073181.
    >> Share

  96. BANN GG, Dos Santos M, Chen K, Tan W, et al
    Cellular Reprogramming by PHF7 Enhances Cardiac Function Following Myocardial Infarction.
    Circulation. 2025 Jul 9. doi: 10.1161/CIRCULATIONAHA.124.072733.
    >> Share

  97. GOUPIL R, Desbiens LC, Merabtine A, Agharazii M, et al
    Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study.
    Circulation. 2025 Jul 9:10.1161/CIRCULATIONAHA.124.073507.
    >> Share

  98. HU Q, Zhang J, Luo X, Hu P, et al
    Intracellular L-PGDS-Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury.
    Circulation. 2025;152:41-57.
    >> Share

  99. HENDREN NS, Ammirati E
    Cardiovascular Effects of COVID-19: Legacy and Future Insights.
    Circulation. 2025;152:24-26.
    >> Share

  100. CUEVAS C, Kikushima-Alcantara P, Miranda JJ
    The State of Cardiovascular Care in Peru: Needs for System Strengthening.
    Circulation. 2025;152:7-10.
    >> Share

    June 2025
  101. GONG Y, Lu X, Wang X, Wang Y, et al
    Mitochondrial Tumor Suppressor 1A Attenuates Myocardial Infarction Injury by Maintaining the Coupling Between Mitochondria and Endoplasmic Reticulum.
    Circulation. 2025 Jun 30. doi: 10.1161/CIRCULATIONAHA.124.069737.
    >> Share

  102. DUAN Z, Lin Z
    Response by Duan and Lin to Letter Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
    Circulation. 2025;151:e1093-e1094.
    >> Share

  103. THRANE PG, Maeng M, Maehara A, Botker HE, et al
    Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.
    Circulation. 2025;151:1767-1779.
    >> Share

  104. WANG H, Zhao T, Zheng G
    Letter by Wang et al Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
    Circulation. 2025;151:e1091-e1092.
    >> Share

  105. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;151:e1098.
    >> Share

  106. BELLAVIA A, Murphy SA
    Confounders, Effect Modifiers, and Mediators: Dealing With "Third Variables" in Cardiovascular Epidemiology.
    Circulation. 2025;151:1755-1757.
    >> Share

  107. JOHNY E, Dutta P
    Targeting Extramedullary Hematopoiesis and Cardiac Immune Homing to Encourage Cardiac Healing After Myocardial Infarction.
    Circulation. 2025;151:1748-1751.
    >> Share

  108. ARNAOUT R
    From Bytes to Beats: Overcoming Conceptual and Implementation Challenges for AI in Cardiovascular Care.
    Circulation. 2025;151:1697-1698.
    >> Share

  109. GRECO M, Lombardi G, Brusasco C, Pieri M, et al
    Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: the PRINCE Randomized Clinical Trial.
    Circulation. 2025 Jun 13. doi: 10.1161/CIRCULATIONAHA.125.075254.
    >> Share

  110. CAMPO G, Pavasini R
    Response by Campo and Pavasini to Letter Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
    Circulation. 2025;151:e1049-e1050.
    >> Share

  111. PAN D, Wu W, Chen M
    Letter by Pan et al Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
    Circulation. 2025;151:e1047-e1048.
    >> Share

  112. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
    Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Jun 9. doi: 10.1161/CIR.0000000000001341.
    >> Share

  113. LEE S, Hwang SH, Park S, Son Y, et al
    Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study.
    Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.073086.
    >> Share

  114. OBEL LM, Skovbo JS, Diederichsen ACP, Thomassen M, et al
    Aortic Aneurysm Risk and Somatic JAK2(V617F)Variation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study.
    Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.074002.
    >> Share

  115. CHU L, Wang R, Gross CP, Wei J, et al
    Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States.
    Circulation. 2025 Jun 3. doi: 10.1161/CIRCULATIONAHA.124.073614.
    >> Share

  116. GREGSON J, Taylor D, Owen R, Collier T, et al
    Hierarchical Composite Outcomes and Win Ratio Methods in Cardiovascular Trials: A Review and Consequent Guidance.
    Circulation. 2025;151:1606-1619.
    >> Share

    May 2025
  117. SCHNEEWEISS S, Kruger N
    Non-Randomized Database Analyses to Complement Randomized Clinical Trials: Promising Approaches for Cardiovascular Medicine.
    Circulation. 2025;151:1495-1497.
    >> Share

  118. BERRY C, McCartney P
    Letter by Berry and McCartney Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (The PITRI Trial)".
    Circulation. 2025;151:e1002-e1003.
    >> Share

  119. BULLUCK H, Hausenloy DJ
    Response by Bulluck and Hausenloy to Letter Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)".
    Circulation. 2025;151:e1004-e1005.
    >> Share

  120. BOHULA EA, Landzberg MJ, Menon V, Alviar CL, et al
    Palliative and End-of-Life Care During Critical Cardiovascular Illness: A Scientific Statement From the American Heart Association.
    Circulation. 2025 May 15. doi: 10.1161/CIR.0000000000001334.
    >> Share

  121. ZHANG Z, Yang X, Zhang Z
    Letter by Zhang et al Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e986-e987.
    >> Share

  122. REITAN C, Andell P, Hofmann R, Jernberg T, et al
    Response by Reitan et al to Letter Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e988-e989.
    >> Share

  123. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
    Correction to: Sedentary Behavior and Light-intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2025;151:e1000.
    >> Share

  124. SATTAR N, Weerakkody GJ, McGuire DK, Kosiborod MN, et al
    The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.
    Circulation. 2025;151:1430-1432.
    >> Share

    April 2025
  125. CLARKE R, Wright N, Lin K, Yu C, et al
    Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study.
    Circulation. 2025 Apr 29. doi: 10.1161/CIRCULATIONAHA.124.072086.
    >> Share

  126. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
    Correction to: Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Circulation. 2025;151:e965-e966.
    >> Share

  127. DONG J, Yang X, Zhang W
    Letter by Dong et al Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e962-e963.
    >> Share

  128. BONNESEN K, Heide-Jorgensen U, Schmidt M
    Response by Bonnesen et al to Letter Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e964.
    >> Share

  129. ISMAHIL MA, Zhou G, Rajasekar S, Gao M, et al
    Splenic CD169(+)Tim4(+) Marginal Metallophilic Macrophages Are Essential for Wound Healing After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.071772.
    >> Share

  130. LV H, Wang C, Liu Z, Quan M, et al
    Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.069420.
    >> Share

  131. BERRY JD, Zabad N, Kyrouac D, Leonard D, et al
    High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study.
    Circulation. 2025 Apr 21. doi: 10.1161/CIRCULATIONAHA.124.070335.
    >> Share

  132. GRAVEN LJ, Kitko L, Abshire Saylor M, Allen L, et al
    Palliative Care and Advanced Cardiovascular Disease in Adults: Not Just End-of-Life Care: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Apr 17. doi: 10.1161/CIR.0000000000001323.
    >> Share

  133. STAMATAKIS E, Biswas RK, Koemel NA, Sabag A, et al
    Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality.
    Circulation. 2025;151:1063-1075.
    >> Share

  134. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
    Sedentary Behavior and Light-Intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2025 Apr 10. doi: 10.1161/CIR.0000000000001316.
    >> Share

  135. CHEN Q, Zheng A, Xu X, Shi Z, et al
    Nrf3-Mediated Mitochondrial Superoxide Promotes Cardiomyocyte Apoptosis and Impairs Cardiac Functions by Suppressing Pitx2.
    Circulation. 2025;151:1024-1046.
    >> Share

  136. LAM NT, Nguyen NUN, Elhelaly WM, Hsu CC, et al
    Induced Cytokinesis Generates Highly Proliferative Mononuclear Cardiomyocytes at the Expense of Contractility.
    Circulation. 2025;151:1009-1023.
    >> Share

  137. BENOWITZ NL
    Predicting Cardiovascular Risk With Use of Various Tobacco Products.
    Circulation. 2025;151:1006-1008.
    >> Share

  138. STEG PG, Szarek M, Jukema JW, Bhatt DL, et al
    Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of O
    Circulation. 2025;151:1047-1050.
    >> Share

  139. POWELL-WILEY TM, Brewer LC, Burke LE, Hernandez R, et al
    Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Apr 7. doi: 10.1161/CIR.0000000000001314.
    >> Share

  140. SITTICHOKKANANON A, Garfield V, Chiesa ST
    Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes.
    Circulation. 2025 Apr 4. doi: 10.1161/CIRCULATIONAHA.124.070632.
    >> Share

  141. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;151:e865.
    >> Share

  142. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
    Correction to: Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025;151:e864.
    >> Share

  143. YU M, Cheng X
    Response by Yu and Cheng to Letter Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
    Circulation. 2025;151:e769-e770.
    >> Share

  144. KAKIZAKI R, Raber L
    Letter by Kakizaki and Raber Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
    Circulation. 2025;151:e767-e768.
    >> Share

    March 2025
  145. MARX N, Deanfield JE, Mann JFE, Arechavaleta R, et al
    Oral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
    Circulation. 2025 Mar 29. doi: 10.1161/CIRCULATIONAHA.125.074545.
    >> Share

  146. BAIREY MERZ CN, Bonow RO, Carnethon M, Crea F, et al
    Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.
    Circulation. 2025 Mar 28. doi: 10.1161/CIRCULATIONAHA.125.074517.
    >> Share

  147. RYAN TD, Bates JE, Kinahan KE, Leger KJ, et al
    Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Mar 19. doi: 10.1161/CIR.0000000000001308.
    >> Share

  148. NDUMELE CE, Ferdinand KC, Khan SS
    The Role of Race in Cardiovascular Disease Risk Prediction.
    Circulation. 2025;151:741-743.
    >> Share

  149. HULL LE, Aday AW, Bui QM, Luzum JA, et al
    Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Mar 13. doi: 10.1161/CIR.0000000000001304.
    >> Share

  150. KURAMITSU S, Kawase Y, Shinozaki T, Domei T, et al
    Prevalence and Clinical Outcomes of Discordant Lesions Between Fractional Flow Reserve and Nonhyperemic Pressure Ratios in Clinical Practice: The J-PRIDE Registry.
    Circulation. 2025;151:672-685.
    >> Share

  151. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
    Correction to: Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
    Circulation. 2025;151:e709.
    >> Share

  152. CLAUDEL SE, Verma A
    Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review.
    Circulation. 2025;151:716-732.
    >> Share

  153. ARUNOTHAYARAJ S, Egred M, Banning AP, Brunel P, et al
    Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.
    Circulation. 2025;151:612-622.
    >> Share

  154. KOU S, Lu Z, Deng D, Ye M, et al
    Activation of Imprinted Gene PW1 Promotes Cardiac Fibrosis After Ischemic Injury.
    Circulation. 2025;151:623-639.
    >> Share

    February 2025
  155. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025 Feb 27. doi: 10.1161/CIR.0000000000001309.
    >> Share


  156. Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017.
    Circulation. 2025;151:e681.
    >> Share


  157. Correction to: Abstract 4139303: Temporal Trends in Cardiovascular Risk Factors and Cardiovascular Disease among Middle Eastern Immigrants in the National Health Interview Survey 2004-2018.
    Circulation. 2025;151:e680.
    >> Share

  158. STARK AW, Matthey-de-l'Endroit RL, Ferroni A, Kakizaki R, et al
    Coronary CT Anatomy-Based Prediction of Invasively Assessed Hemodynamic Significance in Middle-Aged Patients With Right Coronary Artery Anomaly: The NARCO Study.
    Circulation. 2025;151:578-580.
    >> Share

  159. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
    Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Feb 20. doi: 10.1161/CIR.0000000000001297.
    >> Share

  160. ARMILLOTTA M, Bergamaschi L, Paolisso P, Belmonte M, et al
    Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2025 Feb 19. doi: 10.1161/CIRCULATIONAHA.124.070729.
    >> Share

  161. NELLIPUDI JA, Kelly B, Hardikar A
    Addressing Cardiovascular Health Inequities in Indigenous Women: Insights from Australia and Global Perspectives.
    Circulation. 2025;151:427-429.
    >> Share

  162. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Traerup Andersen J, et al
    Cardiovascular Disease in Anabolic Androgenic Steroid Users.
    Circulation. 2025 Feb 13. doi: 10.1161/CIRCULATIONAHA.124.071117.
    >> Share

  163. KIM SM, Kim S, Kim YJ, Kim WY, et al
    Major Adverse Cardiovascular Events 1 Year After Discharge in Out-of-Hospital Cardiac Arrest Survivors.
    Circulation. 2025;151:421-423.
    >> Share

  164. BRENNAN SO, Kelly PJ, Gorey S, Synnott P, et al
    Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.
    Circulation. 2025;151:334-336.
    >> Share

    January 2025
  165. DAI J, Zhao J, Xu X, Chen Y, et al
    Long-Term Prognostic Implications of Non-Culprit Lesions in Patients Presenting With an Acute Myocardial Infarction: Is It the Angiographic Stenosis Severity or the Underlying High-Risk Morphology?
    Circulation. 2025 Jan 31. doi: 10.1161/CIRCULATIONAHA.124.071855.
    >> Share

  166. HALL EJ, Agarwal S, Cullum CM, Sinha SS, et al
    Survivorship After Cardiogenic Shock.
    Circulation. 2025;151:257-271.
    >> Share

  167. SINGER Z, Wijeysundera HC, Qiu F, Fang J, et al
    Driving Restrictions and Incapacitation Vulnerability Evaluation After ST-Segment-Elevation Myocardial Infarction: DRIVE-STEMI Study.
    Circulation. 2025;151:282-284.
    >> Share


  168. Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
    Circulation. 2025;151:e30.
    >> Share

  169. MAURICIO R, Sharma G, Lewey J, Tompkins R, et al
    Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Jan 15. doi: 10.1161/CIR.0000000000001292.
    >> Share

  170. CHEN JZ, Liang Y, Liang B
    Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
    Circulation. 2025;151:e22.
    >> Share

  171. SUN M, He S, Hu J, Zhang Y, et al
    Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
    Circulation. 2025;151:e23.
    >> Share

  172. SIDIQI AW, Dad Zada D, Exeer NA
    Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine.
    Circulation. 2025;151:129-131.
    >> Share

  173. ROGNE T, Gill D
    Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study.
    Circulation. 2025;151:193-195.
    >> Share

  174. LIU S, Deshmukh V, Meng F, Wang Y, et al
    Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration.
    Circulation. 2025;151:59-75.
    >> Share

  175. CHEW NWS, Mehta A, Goh RSJ, Zhang A, et al
    Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.
    Circulation. 2025;151:98-119.
    >> Share

    December 2024
  176. TOMII D, Pilgrim T, Borger MA, De Backer O, et al
    Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management.
    Circulation. 2024;150:2046-2069.
    >> Share

  177. ZWECK E, Hassager C, Beske RP, Jensen LO, et al
    Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial.
    Circulation. 2024;150:1990-2003.
    >> Share

  178. BIRKENFELD AL, Franks PW, Mohan V
    Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention.
    Circulation. 2024;150:1910-1912.
    >> Share

  179. LEWANDOWSKI AJ, Rutter MK, Collins R
    Scientific and Clinical Impacts of UK Biobank in Cardiovascular Medicine.
    Circulation. 2024;150:1907-1909.
    >> Share

  180. JONE PN, Tremoulet A, Choueiter N, Dominguez SR, et al
    Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2024;150:e481-e500.
    >> Share

  181. DENNISON HIMMELFARB CR, Benowitz NL, Blank MD, Bhatnagar A, et al
    Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association.
    Circulation. 2024 Dec 3. doi: 10.1161/CIR.0000000000001293.
    >> Share

  182. LINDNER JR, Morello M
    In Vivo Cardiovascular Molecular Imaging: Contributions to Precision Medicine and Drug Development.
    Circulation. 2024;150:1885-1897.
    >> Share

  183. ARMBRUSTER S, Skali H, Wei LJ
    Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials.
    Circulation. 2024;150:1823-1825.
    >> Share

    November 2024
  184. QIN D, Modanwal R, Kitsis RN
    Extracellular Role for the Intracellular Cell Death Mediator RIPK3 in Myocardial Infarction.
    Circulation. 2024;150:1812-1814.
    >> Share

  185. ZHANG W, Zhang J, Wang Z, Li T, et al
    Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury.
    Circulation. 2024;150:1791-1811.
    >> Share

  186. ITZHAKI BEN ZADOK O, Simitsis P, Jacobson C, Nadeem O, et al
    Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.
    Circulation. 2024;150:1815-1817.
    >> Share

  187. JI Y, Zhang MJ, Wang W, Norby FL, et al
    Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS.
    Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.124.070278.
    >> Share

  188. MORROW A, Young R, Abraham GR, Hoole S, et al
    Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial.
    Circulation. 2024;150:1671-1683.
    >> Share


  189. Correction to: 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Gui
    Circulation. 2024;150:e466.
    >> Share

  190. GIUGNI FR, Berry JD, Khera A, Shah AM, et al
    Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?
    Circulation. 2024;150:1720-1731.
    >> Share

  191. HO FK, Mark PB, Lees JS, Pell JP, et al
    A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia.
    Circulation. 2024 Nov 14. doi: 10.1161/CIRCULATIONAHA.124.070454.
    >> Share

  192. GREIF R, Bray JE, Djarv T, Drennan IR, et al
    2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
    Circulation. 2024 Nov 14. doi: 10.1161/CIR.0000000000001288.
    >> Share

  193. XU X, Zhu H, Xu K
    Letter by Xu et al Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e444.
    >> Share

  194. LIANG Y, Liang B
    Letter by Y. Liang and B. Liang Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e443.
    >> Share

  195. YAN Y, Nie S, Montalescot G
    Response by Yan et al to Letter Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e445-e446.
    >> Share

  196. DEZFULIAN C, McCallin TE, Bierens J, Dunne CL, et al
    2024 American Heart Association and American Academy of Pediatrics Focused Update on Special Circumstances: Resuscitation Following Drowning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardio
    Circulation. 2024 Nov 12. doi: 10.1161/CIR.0000000000001274.
    >> Share

  197. KIM Y, Landstrom AP, Shah SH, Wu JC, et al
    Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association.
    Circulation. 2024 Nov 11. doi: 10.1161/CIR.0000000000001296.
    >> Share

  198. MA C, Ge J, Han Y
    Global Rounds: Advancing Cardiovascular Health in China.
    Circulation. 2024 Nov 7. doi: 10.1161/CIRCULATIONAHA.124.071544.
    >> Share

  199. AVERBUCH T, Stelkia K, Van Spall HGC
    Cardiovascular Care in Canada: Strengths, Challenges, and Opportunities For Improvement.
    Circulation. 2024;150:1490-1492.
    >> Share

  200. BHATIA HS, Wandel S, Willeit P, Lesogor A, et al
    Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.
    Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.069556.
    >> Share

  201. DILLON HT, Saner NJ, Ilsley T, Kliman DS, et al
    Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.
    Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.070709.
    >> Share

    October 2024
  202. VAN DIEPEN S, Poss J, Senaratne JM, Gage A, et al
    Mixed Cardiogenic Shock: A Proposal for Standardized Classification, a Hemodynamic Definition, and Framework for Management.
    Circulation. 2024;150:1459-1468.
    >> Share

  203. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
    Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
    Circulation. 2024;150:1478-1480.
    >> Share

  204. GRAGNANO F, van Klaveren D, Heg D, Raber L, et al
    Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.
    Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072009.
    >> Share

  205. FOLEY MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, et al
    Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease.
    Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072281.
    >> Share

  206. SELLKE FW
    Bleeding After Cardiovascular Surgery: A Continuing Problem.
    Circulation. 2024;150:1324-1326.
    >> Share

  207. RUEL M, de Lemos J, Fischbein M, Hill JA, et al
    Introduction to the 2024 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2024;150:1307.
    >> Share

  208. HOFMANN C, Serafin A, Schwerdt OM, Fischer J, et al
    Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response.
    Circulation. 2024;150:1248-1267.
    >> Share

  209. SILBERNAGEL G, Chen YQ, Li H, Lemen D, et al
    Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality.
    Circulation. 2024 Oct 11. doi: 10.1161/CIRCULATIONAHA.124.069272.
    >> Share

  210. KRISTENSEN JH, Hasselbalch RB, Strandkjaer N, Jorgensen N, et al
    Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans.
    Circulation. 2024;150:1187-1198.
    >> Share

  211. SINNAEVE PR, Welsh RC, Arias Mendoza A, Ristic AD, et al
    Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up.
    Circulation. 2024;150:1151-1153.
    >> Share

  212. RUEL M, Chikwe J
    Coronary Artery Bypass Grafting: Past and Future.
    Circulation. 2024;150:1067-1069.
    >> Share

  213. KNEUER JM, Grajek IA, Winkler M, Erbe S, et al
    Novel Long Noncoding RNA HEAT4 Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing.
    Circulation. 2024;150:1101-1120.
    >> Share

    September 2024
  214. ZHAO X, Williamson T, Gong Y, Epstein JA, et al
    Immunomodulatory Therapy for Ischemic Heart Disease.
    Circulation. 2024;150:1050-1058.
    >> Share

  215. DUAN Z, Huang Z, Lei W, Zhang K, et al
    Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics.
    Circulation. 2024 Sep 24. doi: 10.1161/CIRCULATIONAHA.123.065935.
    >> Share

  216. GIACOPPO D, Laudani C, Occhipinti G, Spagnolo M, et al
    Response by Giacoppo et al to Letter Regarding Article "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
    Circulation. 2024;150:e271-e272.
    >> Share

  217. ZHANG Z
    Letter by Zhang Regarding Article, "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
    Circulation. 2024;150:e269-e270.
    >> Share

  218. KOTWAL SS, Perkovic V
    Kidney Disease as a Cardiovascular Disease Priority.
    Circulation. 2024;150:975-977.
    >> Share

  219. THOMPSON A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, et al
    2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001285.
    >> Share

  220. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
    Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001289.
    >> Share

  221. LEE DH
    Microplastics and Cardiovascular Diseases: Importance of Coexisting Environmental Pollutants.
    Circulation. 2024;150:908-910.
    >> Share

  222. SHAH NS, Kandula NR, Commodore-Mensah Y, Morey BN, et al
    Social Determinants of Cardiovascular Health in Asian Americans: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Sep 16. doi: 10.1161/CIR.0000000000001278.
    >> Share

  223. BUTALA NM, Bucholz EM
    Quantifying Longevity After Myocardial Infarction: What Is Lost and What Is Gained.
    Circulation. 2024;150:836-837.
    >> Share

  224. BEI Y, Zhu Y, Zhou J, Ai S, et al
    Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury.
    Circulation. 2024;150:848-866.
    >> Share

  225. DIWAN A
    The Case for Restoring Organelles to Treat Ischemic Cardiomyopathy: Is DEPP1 an Attractive Target?
    Circulation. 2024;150:787-790.
    >> Share

  226. WYANT GA, Jiang Q, Singh M, Qayyum S, et al
    Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy.
    Circulation. 2024;150:770-786.
    >> Share

  227. VOLPP KG
    Using Behavioral Science to Improve Cardiovascular Health.
    Circulation. 2024;150:743-745.
    >> Share

  228. SIMON T, Herbert BM, Brooks MM, Goodman SG, et al
    Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial.
    Circulation. 2024 Sep 2. doi: 10.1161/CIRCULATIONAHA.124.069917.
    >> Share

  229. CAMPO G, Bohm F, Engstrom T, Smits PC, et al
    Complete vs. Culprit-Only Revascularization in Older Patients with ST-segment Elevation Myocardial Infarction: An Individual Patient Meta-Analysis.
    Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071493.
    >> Share

    August 2024
  230. BODEN WE, De Caterina R, Kaski JC, Bairey Merz CN, et al
    Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines.
    Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.123.065656.
    >> Share

  231. NEUEN BL, Fletcher RA, Heath L, Perkovic A, et al
    Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071689.
    >> Share

  232. DEFILIPPIS AP, Abbott JD, Herbert BM, Bertolet MH, et al
    Restrictive Versus Liberal Transfusion in Patients with Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the Myocardial Ischemia and Transfusion (MINT) Trial.
    Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.071208.
    >> Share

  233. BONNESEN K, Heide-Jorgensen U, Christensen DH, Lash TL, et al
    Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
    Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.068613.
    >> Share

  234. DELWARDE C, Aikawa M
    Novel Mouse Model of Late-Stage Coronary Atherosclerosis With Features of Plaque Rupture and Stroke.
    Circulation. 2024;150:706-709.
    >> Share

  235. LI J, Sun S, Zhu D, Mei X, et al
    Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.
    Circulation. 2024;150:710-723.
    >> Share

  236. YU M, Yang Y, Dong SL, Zhao C, et al
    Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069808.
    >> Share

  237. KERN MJ, Seto AH
    Does PPG, the Other Dimension to FFR, Better Predict Post-PCI Results?
    Circulation. 2024;150:598-599.
    >> Share

  238. KOBAYASHI H, Tohyama S, Ichimura H, Ohashi N, et al
    Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Circulation. 2024;150:611-621.
    >> Share

  239. KOVILAKATH A, Mauro AG, Valentine YA, Raucci FJ, et al
    SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy.
    Circulation. 2024;150:622-641.
    >> Share

  240. ABBATE A, Van Tassell B, Bogin V, Markley R, et al
    Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
    Circulation. 2024;150:580-582.
    >> Share

  241. MOSLEHI JJ
    Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation.
    Circulation. 2024;150:513-515.
    >> Share

  242. MORRIS SA, Flyer JN, Yetman AT, Quezada E, et al
    Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Aug 12. doi: 10.1161/CIR.0000000000001265.
    >> Share

  243. LIN Y, Gil CH, Banno K, Yokoyama M, et al
    ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels.
    Circulation. 2024;150:451-465.
    >> Share

  244. BITTNER V
    Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention.
    Circulation. 2024;150:435-438.
    >> Share

  245. JOYNT MADDOX KE
    Health Economics of Cardiovascular Disease in the United States.
    Circulation. 2024;150:419-421.
    >> Share

  246. MARTINEZ-MORATA I, Schilling K, Glabonjat RA, Domingo-Relloso A, et al
    Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2024 Aug 1. doi: 10.1161/CIRCULATIONAHA.124.069414.
    >> Share

    July 2024

  247. Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;150:e105.
    >> Share

  248. VALGIMIGLI M, Landi A, Angiolillo DJ, Baber U, et al
    Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome.
    Circulation. 2024;150:317-335.
    >> Share

  249. ARMSTRONG PW
    Global Collaborative Cardiovascular Research: The Collective Wisdom of Countries.
    Circulation. 2024;150:258-260.
    >> Share

  250. GRANT JK, Martin SS, Zhang S, Matsushita K, et al
    Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study.
    Circulation. 2024;150:250-252.
    >> Share

  251. WANG Y, Chen GC, Wang Z, Luo K, et al
    Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL.
    Circulation. 2024;150:215-229.
    >> Share

  252. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
    Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
    Circulation. 2024;150:243-245.
    >> Share

  253. ADEDINSEWO D
    Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility.
    Circulation. 2024;150:174-176.
    >> Share

  254. WEYRICH M, Cremer S, Gerster M, Sarakpi T, et al
    Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease.
    Circulation. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139.
    >> Share

  255. ABBARA S, Shaw LJ
    Past, Present, and Future of CTA.
    Circulation. 2024;150:87-90.
    >> Share

  256. FLEG JL, Huang Z, Reynolds HR, Shaw LJ, et al
    Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA.
    Circulation. 2024;150:165-167.
    >> Share

  257. KUEHN BM
    Million Hearts Model Reduces Cardiovascular Events Without Increasing Care Costs.
    Circulation. 2024;150:162-164.
    >> Share

  258. REITAN C, Andell P, Alfredsson J, Erlinge D, et al
    Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study.
    Circulation. 2024 Jul 5. doi: 10.1161/CIRCULATIONAHA.124.068739.
    >> Share

  259. BERRY C, Sidik NP, McEntegart MB
    Response by Berry et al to Letter Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
    Circulation. 2024;150:e5-e6.
    >> Share

  260. NISHI T, Saito Y, Kobayashi Y
    Letter by Nishi et al Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
    Circulation. 2024;150:e3-e4.
    >> Share

    June 2024
  261. KIM K, Joyce BT, Zheng Y, Nannini DR, et al
    Associations of Urban Blue and Green Spaces With Coronary Artery Calcification in Black Individuals and Disadvantaged Neighborhoods.
    Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.123.067992.
    >> Share

  262. TANNU M, Kaltenbach L, Pagidipati NJ, McGuire DK, et al
    Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.
    Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.124.068962.
    >> Share

  263. LIU T, Hao Y, Zhang Z, Zhou H, et al
    Advanced Cardiac Patches for the Treatment of Myocardial Infarction.
    Circulation. 2024;149:2002-2020.
    >> Share

  264. JHA AK
    Letter by Jha Regarding Article, "Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial".
    Circulation. 2024;149:e1415-e1416.
    >> Share

  265. ZHANG S, Zhang Y, Duan X, Wang B, et al
    Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism.
    Circulation. 2024;149:1982-2001.
    >> Share

  266. SHAMSUZZAMAN S, Deaton RA, Salamon A, Doviak H, et al
    Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.
    Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.123.067931.
    >> Share

  267. MIYAUCHI K, Iwata H, Nishizaki Y, Inoue T, et al
    Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA).
    Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.123.065520.
    >> Share


  268. Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1411.
    >> Share

  269. HUNDLEY WG
    Fifty Years of Cardiovascular Magnetic Resonance: Continuing Evolution Toward the "One-Stop Shop" for Cardiovascular Diagnosis.
    Circulation. 2024;149:1859-1861.
    >> Share

  270. ANDREOTTI F, Burzotta F, Maggioni AP
    Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance".
    Circulation. 2024;149:e1312.
    >> Share

  271. GURAGAIN B, Wei Y, Zhang H, Kahn-Krell A, et al
    Implanted Human Cardiac Spheroids Electrically Couple With Infarcted Swine Myocardium.
    Circulation. 2024;149:1855-1857.
    >> Share

  272. KAZI DS, Elkind MSV, Deutsch A, Dowd WN, et al
    Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001258.
    >> Share

  273. MORAN AE, Goldman L
    Predicting the Future Prevalence of Cardiovascular Disease: The Good, the Bad, the Known, and the Unknown.
    Circulation. 2024 Jun 4. doi: 10.1161/CIRCULATIONAHA.124.070265.
    >> Share

  274. JOYNT MADDOX KE, Elkind MSV, Aparicio HJ, Commodore-Mensah Y, et al
    Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001256.
    >> Share

    May 2024
  275. MEHTA LS, Churchwell K, Coleman D, Davidson J, et al
    Fostering Psychological Safety and Supporting Mental Health Among Cardiovascular Health Care Workers: A Science Advisory From the American Heart Association.
    Circulation. 2024 May 30. doi: 10.1161/CIR.0000000000001259.
    >> Share

  276. NAKAMORI S, Amyar A, Fahmy AS, Ngo LH, et al
    Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
    Circulation. 2024 May 29. doi: 10.1161/CIRCULATIONAHA.123.067107.
    >> Share

  277. CALLER T, Rotem I, Shaihov-Teper O, Lendengolts D, et al
    Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.
    Circulation. 2024;149:1729-1748.
    >> Share

  278. ZHAI X, Cao S, Wang J, Qiao B, et al
    Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification.
    Circulation. 2024;149:1752-1769.
    >> Share


  279. Correction to: 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1218.
    >> Share

  280. SATTAR N, Neeland IJ, McGuire DK
    Obesity and Cardiovascular Disease: A New Dawn.
    Circulation. 2024;149:1621-1623.
    >> Share

  281. ZHU Q, Scherer PE
    Ceramides and Atherosclerotic Cardiovascular Disease: A Current Perspective.
    Circulation. 2024;149:1624-1626.
    >> Share

  282. BULLUCK H, Chong JH, Bryant J, Annathurai A, et al
    Effect of Cangrelor on Infarct Size in ST-Segment Elevation Myocardial Infarction Treated By Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial).
    Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.068938.
    >> Share

  283. COLLET C, Munhoz D, Mizukami T, Sonck J, et al
    Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes.
    Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.069450.
    >> Share


  284. Correction to: An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
    Circulation. 2024;149:e1189-e1190.
    >> Share

  285. TANG WHW, Hazen SL
    Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases.
    Circulation. 2024;149:1543-1545.
    >> Share

  286. MORRISON JT, Canonico ME, Anand SS, Patel MR, et al
    Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
    Circulation. 2024;149:1536-1539.
    >> Share

    April 2024
  287. KELHAM M, Mathur A, Jones DA
    Response by Kelham et al to Letter Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
    Circulation. 2024;149:e1133.
    >> Share

  288. APOSTOLOS A, Karamasis GV, Tsigkas G
    Letter by Apostolos et al Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
    Circulation. 2024;149:e1132.
    >> Share

  289. ZAMAN S, Edwards NC, Chew DP
    Global Rounds: Cardiovascular Care in Australia and New Zealand.
    Circulation. 2024;149:1402-1404.
    >> Share

  290. SOLOMON CG, Landrigan PJ
    Fossil Fuels, Climate Change, and Cardiovascular Disease: A Call to Action.
    Circulation. 2024;149:1400-1401.
    >> Share

  291. LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al
    Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
    Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938.
    >> Share

  292. GIRI J, Kaneko T
    Much Ado About Nothing? CABG or PCI for Left Main Coronary Artery Disease.
    Circulation. 2024;149:1339-1340.
    >> Share

  293. SHAH SH, Gerszten RE
    Sifting for Gold in Terabytes of Data: Illuminating Cardiovascular Biology in the 'Omics Age.
    Circulation. 2024;149:1323-1325.
    >> Share

  294. SWAIN L, Bhave S, Qiao X, Reyelt L, et al
    Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.
    Circulation. 2024;149:1341-1353.
    >> Share


  295. Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1128.
    >> Share

  296. GOLDFARB MJ, Saylor MA, Bozkurt B, Code J, et al
    Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Apr 11. doi: 10.1161/CIR.0000000000001233.
    >> Share

  297. PATEL SM, Kang YM, Im K, Neuen BL, et al
    Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069568.
    >> Share

  298. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
    Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069531.
    >> Share

  299. HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
    Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
    Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
    >> Share

  300. CHO L, Plutzky J, Brennan D, Louie MJ, et al
    Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
    Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.123.067691.
    >> Share

  301. MAEHARA A, Sugizaki Y
    Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?
    Circulation. 2024;149:1087-1089.
    >> Share

  302. BLUMER V, Kanwar MK, Barnett CF, Cowger JA, et al
    Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e1051-e1065.
    >> Share

  303. WU JC, Wilson BH, Fang JC, Hurwitz JL, et al
    Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
    Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.069553.
    >> Share

    March 2024
  304. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
    Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
    Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
    >> Share

  305. LUSEBRINK E, Binzenhofer L, Hering D, Villegas Sierra L, et al
    Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
    Circulation. 2024;149:1033-1052.
    >> Share

  306. SERRUYS PW, Revaiah PC
    The American Heart Association's Centennial and Percutaneous Coronary Intervention's Semi-Centennial.
    Circulation. 2024;149:973-978.
    >> Share

  307. FENG J, Li Y, Li Y, Yin Q, et al
    Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair.
    Circulation. 2024;149:1004-1015.
    >> Share


  308. Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
    Circulation. 2024;149:e1023.
    >> Share

  309. SHUEY MM, Wang Y, Xiang RR, Zou A, et al
    Aggregation and Contextualization of Murine Investigations Improves Discovery of Significant Human Atherosclerotic Cardiovascular Disease Associations.
    Circulation. 2024;149:1056-1058.
    >> Share

  310. TENG Z, Ma Y, Ma X
    Letter by Teng et al Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e960-e961.
    >> Share

  311. FRANGOGIANNIS NG
    Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e962-e963.
    >> Share

  312. MARANO P, Mouapi K, Kim A, Mastali M, et al
    Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease.
    Circulation. 2024;149:970-972.
    >> Share

  313. EVERETT BM
    The Confusing Landscape of Cardiovascular Health Assessment, Promotion, and Prediction.
    Circulation. 2024;149:914-916.
    >> Share

  314. LANDSTROM AP, Chahal CAA, Roden DM, Ho CY, et al
    A Customizable and Peer-Reviewed Curriculum for Cardiovascular Genetics and Genomics.
    Circulation. 2024;149:902-904.
    >> Share

  315. JUNCA G, Delgado V
    Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
    Circulation. 2024;149:822-824.
    >> Share

  316. HEUTS S, Myers PO, Siepe M
    Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:892-893.
    >> Share

  317. RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
    Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:894-895.
    >> Share

  318. ZIMMERMANN FM, Ding VY, Fearon WF
    Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:896.
    >> Share

  319. HAYEK SS, Zaha VG, Bogle C, Deswal A, et al
    Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 11. doi: 10.1161/CIR.0000000000001220.
    >> Share

  320. GABA P, Sabik JF, Murphy SA, Bellavia A, et al
    Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
    Circulation. 2024 Mar 11. doi: 10.1161/CIRCULATIONAHA.123.065571.
    >> Share

  321. ALEXANDER T, Kumbhani DJ, Mullasari Sankardas A
    The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era.
    Circulation. 2024;149:732-733.
    >> Share

  322. RAJAGOPALAN S, Brook RD
    Cardiovascular and Planetary Health: Two Sides of the Same Planet.
    Circulation. 2024;149:729-731.
    >> Share

    February 2024
  323. CHEN Z, Zhang J, He Y
    Letter by Chen et al Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:725-726.
    >> Share

  324. VAN DE WERF F, Sinnaeve P, Welsh RC, Armstrong PW, et al
    Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:727-728.
    >> Share

  325. GAFFEY AE, Rollman BL, Burg MM
    Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component.
    Circulation. 2024;149:641-643.
    >> Share

  326. DZAU VJ, Hodgkinson CP
    RNA Therapeutics for the Cardiovascular System.
    Circulation. 2024;149:707-716.
    >> Share

  327. YAN Y, Guo J, Wang X, Wang G, et al
    Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
    Circulation. 2024 Feb 26. doi: 10.1161/CIRCULATIONAHA.123.067079.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016